• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.XPA 招募 ERCC1 参与核苷酸切除修复 (NER) 通路的构象决定因素:XPA 结合基序的结构与动力学。
Biophys J. 2013 Jun 4;104(11):2503-11. doi: 10.1016/j.bpj.2013.04.023.
2
The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.XPA 结合域的 ERCC1 是核苷酸切除修复所必需的,但不是其他 DNA 修复途径所必需的。
J Biol Chem. 2010 Feb 5;285(6):3705-3712. doi: 10.1074/jbc.M109.067538. Epub 2009 Nov 23.
3
Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.XPA将ERCC1-XPF招募至核苷酸切除修复复合物的结构基础。
EMBO J. 2007 Nov 14;26(22):4768-76. doi: 10.1038/sj.emboj.7601894. Epub 2007 Oct 18.
4
DNA repair gets physical: mapping an XPA-binding site on ERCC1.DNA修复进入实体层面:绘制XPA在ERCC1上的结合位点图谱。
DNA Repair (Amst). 2008 May 3;7(5):819-26. doi: 10.1016/j.dnarep.2008.01.018. Epub 2008 Mar 14.
5
Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization.对人类ERCC1中心结构域上XPA和单链DNA结合表面的分析揭示了亚功能化的证据。
Nucleic Acids Res. 2007;35(17):5789-98. doi: 10.1093/nar/gkm503. Epub 2007 Aug 24.
6
New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.用于联合癌症治疗的核苷酸切除修复(NER)抑制剂的新设计。
J Mol Graph Model. 2016 Apr;65:71-82. doi: 10.1016/j.jmgm.2016.02.010. Epub 2016 Feb 26.
7
Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.DNA 修复 ERCC1/XPA 蛋白-蛋白相互作用的小分子拮抗剂。
ChemMedChem. 2024 Apr 16;19(8):e202300648. doi: 10.1002/cmdc.202300648. Epub 2024 Mar 5.
8
Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach.使用分子动力学和虚拟筛选相结合的方法对ERCC1-XPA相互作用的抑制性动态药效团进行表征。
J Mol Graph Model. 2009 Sep;28(2):113-30. doi: 10.1016/j.jmgm.2009.04.009. Epub 2009 May 4.
9
The role of conformational selection in the molecular recognition of the wild type and mutants XPA67-80 peptides by ERCC1.构象选择在ERCC1对野生型和突变型XPA67 - 80肽进行分子识别中的作用
Proteins. 2015 Jul;83(7):1341-51. doi: 10.1002/prot.24825. Epub 2015 May 29.
10
Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.XPA中阻止与ERCC1结合的突变在核苷酸切除修复中存在缺陷。
Mol Cell Biol. 1995 Apr;15(4):1993-8. doi: 10.1128/MCB.15.4.1993.

引用本文的文献

1
Does the XPA-FEN1 Interaction Concern to Nucleotide Excision Repair or Beyond?XPA-FEN1 相互作用是否与核苷酸切除修复有关?还是另有其他作用?
Biomolecules. 2024 Jul 9;14(7):814. doi: 10.3390/biom14070814.
2
Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.DNA 修复 ERCC1/XPA 蛋白-蛋白相互作用的小分子拮抗剂。
ChemMedChem. 2024 Apr 16;19(8):e202300648. doi: 10.1002/cmdc.202300648. Epub 2024 Mar 5.
3
The XPA Protein-Life under Precise Control.XPA 蛋白——精准控制下的生命。
Cells. 2022 Nov 22;11(23):3723. doi: 10.3390/cells11233723.
4
Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells.硫利达嗪增强顺铂耐药人肺癌细胞中顺铂诱导的DNA损伤。
Evid Based Complement Alternat Med. 2022 Mar 30;2022:3702665. doi: 10.1155/2022/3702665. eCollection 2022.
5
Targeting DNA repair and replication stress in the treatment of ovarian cancer.靶向DNA修复和复制应激在卵巢癌治疗中的应用
Int J Clin Oncol. 2017 Aug;22(4):619-628. doi: 10.1007/s10147-017-1145-7. Epub 2017 Jun 22.
6
Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly.XPA蛋白在核苷酸切除修复途径中的作用:关于大分子组装中结构无序功能的观点。
Comput Struct Biotechnol J. 2015 Dec 8;14:78-85. doi: 10.1016/j.csbj.2015.11.007. eCollection 2016.
7
Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.遗传性乳腺癌中 ERCC4/FANCQ 基因的突变分析。
PLoS One. 2014 Jan 21;9(1):e85334. doi: 10.1371/journal.pone.0085334. eCollection 2014.

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
2
On the Role of Water Models in Quantifying the Binding Free Energy of Highly Conserved Water Molecules in Proteins: The Case of Concanavalin A.在量化蛋白质中高度保守水分子的结合自由能方面水模型的作用:以伴刀豆球蛋白 A 为例。
J Chem Theory Comput. 2011 Oct 11;7(10):3391-8. doi: 10.1021/ct200404z. Epub 2011 Sep 1.
3
DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.DNA 修复内切酶 ERCC1-XPF 作为一种克服癌症治疗中化疗耐药性的新型治疗靶点。
Nucleic Acids Res. 2012 Nov 1;40(20):9990-10004. doi: 10.1093/nar/gks818. Epub 2012 Aug 31.
4
DNA repair inhibitors: the next major step to improve cancer therapy.DNA 修复抑制剂:提高癌症治疗水平的下一个重要步骤。
Curr Top Med Chem. 2012;12(12):1376-90. doi: 10.2174/156802612801319070.
5
The mechanism for proton pumping in cytochrome c oxidase from an electrostatic and quantum chemical perspective.从静电学和量子化学角度看细胞色素c氧化酶中质子泵浦的机制。
Biochim Biophys Acta. 2012 Apr;1817(4):495-505. doi: 10.1016/j.bbabio.2011.09.014. Epub 2011 Sep 28.
6
Cellular responses to Cisplatin-induced DNA damage.细胞对顺铂诱导的DNA损伤的反应。
J Nucleic Acids. 2010 Aug 8;2010:201367. doi: 10.4061/2010/201367.
7
Scrutinizing molecular mechanics force fields on the submicrosecond timescale with NMR data.用 NMR 数据在亚微秒时间尺度上仔细研究分子力学力场。
Biophys J. 2010 Jul 21;99(2):647-55. doi: 10.1016/j.bpj.2010.04.062.
8
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.XPF-ERCC1 的下调增强了癌细胞中顺铂的疗效。
DNA Repair (Amst). 2010 Jul 1;9(7):745-53. doi: 10.1016/j.dnarep.2010.03.010. Epub 2010 Apr 24.
9
The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.XPA 结合域的 ERCC1 是核苷酸切除修复所必需的,但不是其他 DNA 修复途径所必需的。
J Biol Chem. 2010 Feb 5;285(6):3705-3712. doi: 10.1074/jbc.M109.067538. Epub 2009 Nov 23.
10
Evaluating the performance of the ff99SB force field based on NMR scalar coupling data.基于核磁共振标量耦合数据评估ff99SB力场的性能。
Biophys J. 2009 Aug 5;97(3):853-6. doi: 10.1016/j.bpj.2009.04.063.

XPA 招募 ERCC1 参与核苷酸切除修复 (NER) 通路的构象决定因素:XPA 结合基序的结构与动力学。

Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.

机构信息

School of Chemistry, National University of Ireland Galway, Galway, Ireland.

出版信息

Biophys J. 2013 Jun 4;104(11):2503-11. doi: 10.1016/j.bpj.2013.04.023.

DOI:10.1016/j.bpj.2013.04.023
PMID:23746523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3672865/
Abstract

XPA is an essential protein in the nucleotide excision repair (NER) pathway, in charge of recruiting the ERCC1-XPF endonuclease complex to the DNA damage site. The only currently available structural insight into the binding of XPA to ERCC1 derives from the solution NMR structure of a complex between the ERCC1 central fragment and a 14-residue peptide, corresponding to the highly conserved binding motif of the XPA N-terminus, XPA₆₇₋₈₀. The extensive all-atom molecular-dynamics simulation study of the XPA₆₇₋₈₀ peptide both bound to the ERCC1 central fragment and free in solution presented here completes the profile of the structural determinants responsible for the ERCC1/XPA₆₇₋₈₀ complex stability. In addition to the wild-type, this study also looks at specific XPA₆₇₋₈₀ mutants in complex with the ERCC1 central domain and thus contributes to defining the conformational determinants for binding, as well as all of the essential structural elements necessary for the rational design of an XPA-based, ERCC1-specific inhibitor.

摘要

XPA 是核苷酸切除修复(NER)途径中的一种必需蛋白,负责将 ERCC1-XPF 内切酶复合物招募到 DNA 损伤部位。目前唯一可用的关于 XPA 与 ERCC1 结合的结构见解来自于 ERCC1 中心片段与 14 个残基肽之间复合物的溶液 NMR 结构,该肽对应于 XPA N 端高度保守的结合基序 XPA₆₇₋₈₀。本文中提出的对结合 ERCC1 中心片段的 XPA₆₇₋₈₀ 肽以及游离于溶液中的 XPA₆₇₋₈₀ 肽的全原子分子动力学模拟研究,完整描绘了决定 ERCC1/XPA₆₇₋₈₀ 复合物稳定性的结构决定因素。除了野生型,这项研究还研究了与 ERCC1 中心结构域结合的特定 XPA₆₇₋₈₀ 突变体,因此有助于确定结合的构象决定因素,以及基于 XPA 的、针对 ERCC1 的抑制剂的合理设计所需的所有基本结构要素。